New Insights in the Treatment of Atrial Fibrillation

[1] Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (17) : 1790 - 1798

[2] 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) [J]. EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2281 - 2329

[3] 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design [J]. EUROPACE, 2012, 14 (04): : 528 - 606

[4] Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]

[5] EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary [J]. EUROPEAN HEART JOURNAL, 2013, 34 (27) : 2094 - 2106

[6] Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2010, 3 (02) : 141 - U44

[7] Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry [J]. PLOS ONE, 2013, 8 (05):

[8] Kirchhof P, 2013, MANAGEMENT ATRIAL FI

[9] KIRCHHOF P, 2013, P 4 ATR FIBR COMP NE, V15, P1540

[10] Meincke F, 2013, EUROINTERVENTION, V9, P463, DOI 10.4244/EIJV9I4A75

[1] Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (17) : 1790 - 1798

[2] 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) [J]. EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2281 - 2329

[3] 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design [J]. EUROPACE, 2012, 14 (04): : 528 - 606

[4] Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]

[5] EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary [J]. EUROPEAN HEART JOURNAL, 2013, 34 (27) : 2094 - 2106

[6] Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2010, 3 (02) : 141 - U44

[7] Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry [J]. PLOS ONE, 2013, 8 (05):

[8] Kirchhof P, 2013, MANAGEMENT ATRIAL FI

[9] KIRCHHOF P, 2013, P 4 ATR FIBR COMP NE, V15, P1540

[10] Meincke F, 2013, EUROINTERVENTION, V9, P463, DOI 10.4244/EIJV9I4A75